Singapore: Japan is all set to host the 13th International Nanotechnology Exhibition and Conference, for three days from...
Singapore: Global phase III clinical trial of once-daily edoxaban for the treatment of acute symptomatic deep vein throm...
Singapore: UCB Japan received marketing approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for Cim...
Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...
Bangalore: Seoul-based Ildong has received a marketing and manufacturing approval for idiopathic pulmonary fibrosis (IPF...
Singapore: Iranian health Minister, Dr Hassan Hashemi has signed an MoU with Japan's Minister for Health Labor and Welfa...
May 3, 2016: Australia-based Prima BioMed Ltd has announced that the company has been granted patent number 5908210 enti...
The entire world is worried about drying up of research pipelines and continued decline in research productivity. This m...
Singapore: Pharmaceutical Product Development (PPD) and Shin Nippon Biomedical Laboratories have formed a joint venture ...
Japanese pharma giant Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center has signed an option ag...
Singapore: Elsevier, a world-leading provider of scientific, technical and medical information products and services, h...
Singapore: Japan's Fujifilm has inked a deal to acquire US-based Kalon Bio therapeutics, which has expertise in manufact...
Japanese pharma major Daiichi Sankyo Company Limited has launched Methylene Blue Injection 50mg for the treatment of met...
HUYA Bioscience International (HUYA) has completed the first cohort in a Phase 1 clinical trial in Japan of its cancer d...
US-based Amgen has announced that an application seeking marketing approval of Repatha (evolocumab) for the treatment of...
Industry forecasts by market analysts state that 80 percent of the multinational companies expect to gain a good share i...
Singapore: A recent report released by RnRMarketResearch.com has analyzed the Global Biochips Industry and forecasted th...
The Global Health Innovative Technology Fund (GHIT Fund) - a unique public health partnership that brings Japanese know-...
